|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1999-10-18
|
|
pubmed:abstractText |
The current treatment of advanced urothelial carcinoma generates high response rates but is associated with poor overall survival. The current study evaluated the efficacy and toxicity of a new combination of active drugs in the treatment of urothelial carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 1999 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1329-34
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10506721-Adult,
pubmed-meshheading:10506721-Aged,
pubmed-meshheading:10506721-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10506721-Carcinoma, Transitional Cell,
pubmed-meshheading:10506721-Cisplatin,
pubmed-meshheading:10506721-Female,
pubmed-meshheading:10506721-Fluorouracil,
pubmed-meshheading:10506721-Follow-Up Studies,
pubmed-meshheading:10506721-Humans,
pubmed-meshheading:10506721-Kidney Neoplasms,
pubmed-meshheading:10506721-Leucovorin,
pubmed-meshheading:10506721-Male,
pubmed-meshheading:10506721-Methotrexate,
pubmed-meshheading:10506721-Middle Aged,
pubmed-meshheading:10506721-Neoplasm Invasiveness,
pubmed-meshheading:10506721-Neoplasm Metastasis,
pubmed-meshheading:10506721-Survival Rate,
pubmed-meshheading:10506721-Urinary Bladder Neoplasms
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma.
|
|
pubmed:affiliation |
Lank Center for Genitourinary Oncology, Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
